John F. Paolini insider trades: Kiniksa Pharmaceuticals International (KNSA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | KNSA | ↓ Sell | 96,000 | $93.09 | $8.9M | Direct | Nov 3, 2026 (1d) |
| May 1, 2026 | KNSA | ↓ Sell | 58,424 | $53.71 | $3.1M | Direct | May 5, 2026 (4d) |
| Mar 2, 2026 | KNSA | ↓ Sell | 40,000 | $44.82 | $1.8M | Direct | Mar 4, 2026 (2d) |
| Oct 31, 2025 | KNSA | ↓ Sell | 82,542 | $37.14 | $3.1M | Direct | Nov 4, 2025 (4d) |
| Aug 6, 2025 | KNSA | ↓ Sell | 29,325 | $32.55 | $955K | Direct | Aug 8, 2025 (2d) |
| May 7, 2025 | KNSA | ↓ Sell | 200 | $27.00 | $5K | Direct | May 9, 2025 (2d) |
| Sep 3, 2024 | KNSA | ↓ Sell | 60,692 | $26.12 | $1.6M | Direct | Sep 4, 2024 (1d) |
| Jul 23, 2024 | KNSA | ↓ Sell | 22,000 | $26.32 | $579K | Direct | Jul 25, 2024 (2d) |
| Mar 1, 2024 | KNSA | ↓ Sell | 18,844 | $21.77 | $410K | Direct | Mar 5, 2024 (4d) |
| Feb 27, 2024 | KNSA | ↓ Sell | 10,156 | $21.03 | $214K | Direct | Feb 29, 2024 (2d) |
| Dec 7, 2023 | KNSA | ↓ Sell | 28,600 | $17.65 | $505K | Direct | Dec 11, 2023 (4d) |
| Sep 5, 2023 | KNSA | ↓ Sell | 400 | $17.53 | $7K | Direct | Sep 6, 2023 (1d) |
| Jul 25, 2023 | KNSA | ↓ Sell | 29,000 | $19.14 | $555K | Direct | Jul 27, 2023 (2d) |
| Nov 7, 2022 | KNSA | ↓ Sell | 28,357 | $15.18 | $430K | Direct | Nov 9, 2022 (2d) |
| Feb 20, 2020 | KNSA | ↓ Sell | 32,280 | $18.48 | $596K | Direct | Feb 21, 2020 (1d) |
| Feb 14, 2020 | KNSA | ↓ Sell | 11,316 | $18.29 | $207K | Direct | Feb 18, 2020 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KNSA insiders
Open-market trades in the last 12 months
About John F. Paolini's insider trades
John F. Paolini is Chief Medical Officer at Kiniksa Pharmaceuticals International (KNSA). Since Feb 14, 2020, John has reported no open-market purchases and 16 sales worth $23.0M on SEC Form 4. In the last 12 months: 3 sales ($13.9M).
Their filings also include option exercises (33 filings), grants and awards (19 filings), shares withheld for taxes (16 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KNSA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.